July

ERJ Podcast Eur Respir J 2011; 37: E7
Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? Restrepo M.I., Mortensen E.M., Anzueto A. Eur Respir J 2011; 37: 1-3
Playing a dirty trick on airway smooth muscle: house dust mite does it again Zuyderduyn S., Hiemstra P.S. Eur Respir J 2011; 37: 4-6
What is this thing called somnolence? Rodenstein D. Eur Respir J 2011; 37: 7-8
Prescribing and guidelines: both must improve to combat antimicrobial resistance Woodhead M. Eur Respir J 2011; 37: 9-11
MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung Müller-Quernheim J. Eur Respir J 2011; 37: 12-14
Glutathione S-transferase copy number variation alters lung gene expression Butler M.W., Hackett N.R., Salit J., Strulovici-Barel Y., Omberg L., Mezey J., Crystal R.G. Eur Respir J 2011; 37: 15-28
Properties of the COPD assessment test in a cross-sectional European study Jones P.W., Brusselle G., Dal Negro R.W., Ferrer M., Kardos P., Levy M.L., Perez T., Soler Cataluña J.J., van der Molen T., Adamek L., Banik N. Eur Respir J 2011; 37: 29-35
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Singanayagam A., Chalmers J.D., Akram A.R., Hill A.T. Eur Respir J 2011; 37: 36-41
Asthma and comorbid medical illness Cazzola M., Calzetta L., Bettoncelli G., Novelli L., Cricelli C., Rogliani P. Eur Respir J 2011; 37: 42-49
House dust mite extract downregulates C/EBP? in asthmatic bronchial smooth muscle cells Miglino N., Roth M., Tamm M., Borger P. Eur Respir J 2011; 37: 50-58
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis Wilschanski M., Miller L.L., Shoseyov D., Blau H., Rivlin J., Aviram M., Cohen M., Armoni S., Yaakov Y., Pugatch T., Cohen-Cymberknoh M., Miller N.L., Reha A., Northcutt V.J., Hirawat S., Donnelly K., Elfring G.L., Ajayi T., Kerem E. Eur Respir J 2011; 37: 59-69
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Hislop A.A., Moledina S., Foster H., Schulze-Neick I., Haworth S.G. Eur Respir J 2011; 37: 70-77
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl Wang L., Chiang E.T., Simmons J.T., Garcia J.G.N., Dudek S.M. Eur Respir J 2011; 37: 78-88
Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Kimoff R.J., Hamid Q., Divangahi M., Hussain S., Bao W., Naor N., Payne R.J., Ariyarajah A., Mulrain K., Petrof B.J. Eur Respir J 2011; 37: 89-97
Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms Vernet C., Redolfi S., Attali V., Konofal E., Brion A., Frija-Orvoen E., Pottier M., Similowski T., Arnulf I. Eur Respir J 2011; 37: 98-105
Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic Riquelme R., Torres A., Rioseco M.L., Ewig S., Cillóniz C., Riquelme M., Inzunza C., Polverino E., Gomez Y., Marcos M.A., Contreras C., Gabarrús A., Fasce R. Eur Respir J 2011; 37: 106-111
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines Wood J., Butler C.C., Hood K., Kelly M.J., Verheij T., Little P., Torres A., Blasi F., Schaberg T., Goossens H., Nuttall J., Coenen S. Eur Respir J 2011; 37: 112-118
Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection Butler C.C., Kelly M.J., Hood K., Schaberg T., Melbye H., Serra-Prat M., Blasi F., Little P., Verheij T., Mölstad S., Godycki-Cwirko M., Edwards P., Almirall J., Torres A., Rautakorpi U-M., Nuttall J., Goossens H., Coenen S. Eur Respir J 2011; 37: 119-125
Spontaneous pneumothorax and tuberculosis: long-term follow-up Freixinet J.L., Caminero J.A., Marchena J., Rodríguez P.M., Casimiro J.A., Hussein M. Eur Respir J 2011; 37: 126-131
Exposure to combustion of solid fuel and tuberculosis: a matched case–control study Gninafon M., Ade G., Aït-Khaled N., Enarson D.A., Chiang C-Y. Eur Respir J 2011; 37: 132-138
High prevalence of smoking among patients with suspected tuberculosis in South Africa Brunet L., Pai M., Davids V., Ling D., Paradis G., Lenders L., Meldau R., van Zyl Smit R., Calligaro G., Allwood B., Dawson R., Dheda K. Eur Respir J 2011; 37: 139-146
Influenza vaccination is associated with reduced severity of community-acquired pneumonia Tessmer A., Welte T., Schmidt-Ott R., Eberle S., Barten G., Suttorp N., Schaberg T. Eur Respir J 2011; 37: 147-153
Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial van den Bergh K.A.M., Essink-Bot M.L., Borsboom G.J.J.M., Scholten E.T., van Klaveren R.J., de Koning H.J. Eur Respir J 2011; 37: 154-161
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Frauenfelder T., Tutic M., Weder W., Götti R.P., Stahel R.A., Seifert B., Opitz I. Eur Respir J 2011; 37: 162-168
Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis Pabst S., Fränken T., Schönau J., Stier S., Nickenig G., Meyer R., Skowasch D., Grohé C. Eur Respir J 2011; 37: 169-175
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Schmidt S.L., Nambiar A.M., Tayob N., Sundaram B., Han M.K., Gross B.H., Kazerooni E.A., Chughtai A.R., Lagstein A., Myers J.L., Murray S., Toews G.B., Martinez F.J., Flaherty K.R. Eur Respir J 2011; 37: 176-183
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression Goh N.S.L., Desai S.R., Anagnostopoulos C., Hansell D.M., Hoyles R.K., Sato H., Denton C.P., Black C.M., du Bois R.M., Wells A.U. Eur Respir J 2011; 37: 184-190
Biological role of matrix metalloproteinases: a critical balance Löffek S., Schilling O., Franzke C-W. Eur Respir J 2011; 37: 191-208
Selected clinical highlights from the 2010 ERS Congress in Barcelona Robalo Cordeiro C., Singh S., Herth F.J.F., Ley S., Chavannes N.H., Clini E., Cottin V. Eur Respir J 2011; 37: 209-217
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia Dumitrescu D., Seck C., ten Freyhaus Henrik., Gerhardt F., Erdmann E., Rosenkranz S. Eur Respir J 2011; 37: 218-220
Influence of pre-analytic conditions on the rate of indeterminate T-SPOT®.TB tests Zellweger A., Zellweger J-P. Eur Respir J 2011; 37: 221-222
Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey Samo Gudo P., Cuna Z., Coelho E., Maungate S., Borroni E., Miotto P., Ahmadova S., Brouwer M., Migliori G.B., Zignol M., Cirillo D.M. Eur Respir J 2011; 37: 222-224
Attitudes, training and smoking profile of European Respiratory Society members Kabir Z., Ward B., Clancy L. Eur Respir J 2011; 37: 225-227
Shorter treatment duration for selected patients with multidrug-resistant tuberculosis Leung E.C.C., Yew W.W., Leung C.C., Leung W.M., Tam C.M. Eur Respir J 2011; 37: 227-230
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach Bassukas I.D., Gaitanis G., Constantopoulos S.H. Eur Respir J 2011; 37: 231-232
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach Lange C., Rieder H., Sester M., Milburn H., Kampmann B., Migliori G.B., Solovic I. Eur Respir J 2011; 37: 232-233
Internal consistency of reference equations Verbanck S., Vandevoorde J., Vincken W. Eur Respir J 2011; 37: 233-234
Internal consistency of reference equations Quanjer P.H., Stocks J., Stanojevic S. Eur Respir J 2011; 37: 234-235